Item Type | Name |
Academic Article
|
Phase I dose and sequencing study of pegylated liposomal doxorubicin and docetaxel in patients with advanced malignancies.
|
Academic Article
|
Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential.
|
Academic Article
|
Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.
|
Academic Article
|
Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma.
|
Academic Article
|
Primary peritoneal carcinoma presenting as adenocarcinoma on a Pap smear. A case report.
|
Academic Article
|
Acute abdominal pain with a calcified pelvic mass.
|
Academic Article
|
A relationship between methylenetetrahydrofolate reductase variants and the development of invasive cervical cancer.
|
Academic Article
|
Denaturing high-performance liquid chromatography for detecting and typing genital human papillomavirus.
|
Academic Article
|
Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation.
|
Academic Article
|
Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome.
|
Academic Article
|
Lymph node control in cervical cancer.
|
Academic Article
|
A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
|
Academic Article
|
Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history.
|
Academic Article
|
A phase II study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian cancer.
|
Academic Article
|
Resource utilization for ovarian cancer patients at the end of life: how much is too much?
|
Academic Article
|
Relationship of ovarian neoplasms and body mass index.
|
Academic Article
|
Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignancies.
|
Academic Article
|
Cervical sarcomas: an analysis of incidence and outcome.
|
Academic Article
|
Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists.
|
Academic Article
|
Spindle cell ossifying amyloidotic tumor of the fallopian tube.
|
Academic Article
|
Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET.
|
Academic Article
|
MLH3 mutation in endometrial cancer.
|
Academic Article
|
Panniculectomy: improving lymph node yield in morbidly obese patients with endometrial neoplasms.
|
Academic Article
|
IGSF4 promoter methylation and expression silencing in human cervical cancer.
|
Academic Article
|
Cervical carcinoma in the elderly: an analysis of patterns of care and outcome.
|
Academic Article
|
Human papillomavirus type and tobacco use as predictors of survival in early stage cervical carcinoma.
|
Academic Article
|
Cervical dysplasia in adolescents.
|
Academic Article
|
Ultrasonic surgical aspiration in the treatment of vulvar disease.
|
Academic Article
|
Liquid-based cytology for the postirradiation surveillance of women with gynecologic malignancies.
|
Academic Article
|
A randomized phase II evaluation of bryostatin-1 (NSC #339555) in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study.
|
Academic Article
|
Synchronous ovarian metastases at the time of laparotomy for colon cancer.
|
Academic Article
|
Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography.
|
Academic Article
|
CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan.
|
Academic Article
|
Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply?
|
Academic Article
|
External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer.
|
Academic Article
|
Prognostic factors associated with response in platinum retreatment of platinum-resistant ovarian cancer.
|
Academic Article
|
Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer.
|
Academic Article
|
Ileal hemorrhage caused by a parasitic uterine leiomyoma.
|
Academic Article
|
Cardiac arrest during laparotomy with argon beam coagulation of metastatic ovarian cancer.
|
Academic Article
|
Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth.
|
Academic Article
|
Human papillomavirus triage for young women with atypical squamous cells of undetermined significance.
|
Academic Article
|
Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer.
|
Academic Article
|
Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma.
|
Academic Article
|
Cervix carcinoma, concurrent chemoradiotherapy, and salvage of isolated paraaortic lymph node recurrence.
|
Academic Article
|
Bevacizumab therapy in patients with recurrent uterine neoplasms.
|
Academic Article
|
Long-term assessment of bladder and bowel dysfunction after radical hysterectomy.
|
Academic Article
|
ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes.
|
Academic Article
|
Acute toxicity of postoperative IMRT and chemotherapy for endometrial cancer.
|
Academic Article
|
Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning.
|
Academic Article
|
Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A Gynecologic Oncology Group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiation.
|
Academic Article
|
Evaluation of candidate methylation markers to detect cervical neoplasia.
|
Academic Article
|
Differential display identifies overexpression of the USP36 gene, encoding a deubiquitinating enzyme, in ovarian cancer.
|
Academic Article
|
Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy.
|
Academic Article
|
Cost-benefit of laparoscopic versus medical ovarian suppression in premenopausal breast cancer.
|
Academic Article
|
Colposcopic accuracy of obstetrics and gynecology residents.
|
Academic Article
|
A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies.
|
Academic Article
|
Cervical tissue collection methods for RNA preservation: comparison of snap-frozen, ethanol-fixed, and RNAlater-fixation.
|
Academic Article
|
Gene expression patterns in advanced human cervical cancer.
|
Academic Article
|
CD83 polymorphisms and cervical cancer risk.
|
Academic Article
|
HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer.
|
Academic Article
|
Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer.
|
Academic Article
|
Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer.
|
Academic Article
|
Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer.
|
Academic Article
|
The value of perioperative imaging in patients with uterine sarcomas.
|
Academic Article
|
A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer.
|
Academic Article
|
Detection of transcripts of human papillomaviruses 16 and 18 in cancer-derived cell lines and cervical biopsies by enzyme immunoassay for DNA-RNA hybrids following solution hybridization.
|
Academic Article
|
Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer.
|
Academic Article
|
Genomics of cervical cancer and the role of human papillomavirus pathobiology.
|
Academic Article
|
Cervical cancer histology and tumor differentiation affect 18F-fluorodeoxyglucose uptake.
|
Academic Article
|
Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer.
|
Academic Article
|
Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy.
|
Academic Article
|
Association between DQB1 and cervical cancer in patients with human papillomavirus and family controls.
|
Academic Article
|
In vitro differentiation of epithelial cells from cervical neoplasias resembles in vivo lesions.
|
Academic Article
|
Double cervix with bilateral and synchronous HSIL associated with different high-risk HPV types. A case report.
|
Academic Article
|
Expression and localization of GRP75 in human epithelial tumors and normal tissues.
|
Academic Article
|
Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study.
|
Academic Article
|
Use of complementary and alternative medicine among women with gynecologic cancers.
|
Academic Article
|
Radiation therapy in the treatment of cervical cancer: the University of Chicago/Michael Reese Hospital experience.
|
Academic Article
|
"Surgical Apgar Score" predicts postoperative complications after cytoreduction for advanced ovarian cancer.
|
Academic Article
|
FDG-PET evaluation of vaginal carcinoma.
|
Academic Article
|
TP53, MDM2, NQO1, and susceptibility to cervical cancer.
|
Academic Article
|
The mons pubis: an excellent graft donor site in gynecologic surgery.
|
Academic Article
|
CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer.
|
Academic Article
|
Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors.
|
Academic Article
|
Analysis of exposure times and dose escalation of paclitaxel in ovarian cancer cell lines.
|
Academic Article
|
Microsatellite instability and mutational analysis of transforming growth factor beta receptor type II gene (TGFBR2) in sporadic ovarian cancer.
|
Academic Article
|
Mutation screening analysis of the retinoblastoma related gene RB2/p130 in sporadic ovarian cancer and head and neck squamous cell cancer.
|
Academic Article
|
Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
|
Academic Article
|
Expression of alpha(v)beta3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas.
|
Academic Article
|
Absence of PTEN repeat tract mutation in endometrial cancers with microsatellite instability.
|
Academic Article
|
Phase II evaluation of a 3-day infusion of topotecan in patients with recurrent ovarian or primary peritoneal cancer.
|
Academic Article
|
Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.
|
Academic Article
|
In situ localization of parathyroid hormone-like protein and mRNA in intraepithelial neoplasia and invasive carcinoma of the uterine cervix.
|
Academic Article
|
Potential of cervical electrosurgical excision procedure for diagnosis and treatment of cervical intraepithelial neoplasia.
|
Academic Article
|
Mapping an endometrial cancer tumor suppressor gene at 10q25 and development of a bacterial clone contig for the consensus deletion interval.
|
Academic Article
|
Genetic variations in EGFR and ERBB4 increase susceptibility to cervical cancer.
|
Academic Article
|
Allelotyping of all chromosomal arms in invasive cervical cancer.
|
Academic Article
|
Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.
|
Academic Article
|
Atypical clustering of gynecologic malignancies: A family study including molecular analysis of candidate genes.
|
Academic Article
|
HPV-16 viral transcripts in vulvar neoplasia: preliminary studies.
|
Academic Article
|
Therapeutic advances in ovarian cancer.
|
Academic Article
|
Fine mapping and evaluation of candidate genes for cervical cancer on 11q23.
|
Academic Article
|
No evidence for BCL10 mutation in endometrial cancers with microsatellite instability.
|
Academic Article
|
Analysis of MSH3 in endometrial cancers with defective DNA mismatch repair.
|
Academic Article
|
Mutational analysis of MLH1 and MSH2 in 25 prospectively-acquired RER+ endometrial cancers.
|
Academic Article
|
Genotypic and phenotypic progression in endometrial tumorigenesis: determining when defects in DNA mismatch repair and KRAS2 occur.
|
Academic Article
|
The significance of pneumatosis intestinalis or bowel perforation in patients with gynecologic malignancies.
|
Academic Article
|
Role of the ultrasonic surgical aspirator in gynecology.
|
Academic Article
|
Microsatellite instability, MLH1 promoter methylation, and loss of mismatch repair in endometrial cancer and concomitant atypical hyperplasia.
|
Academic Article
|
18F-fluorodeoxyglucose-positron emission tomography and pathologic tumor size in early-stage invasive cervical cancer.
|
Academic Article
|
Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: A retrospective analysis.
|
Academic Article
|
Mutational analysis of the PMS2 gene in sporadic endometrial cancers with microsatellite instability.
|
Academic Article
|
Body mass index: relationship to clinical, pathologic and features of microsatellite instability in endometrial cancer.
|
Academic Article
|
A comparison of wound healing after epithelial resection by ultrasonic surgical aspiration and ablation by the carbon dioxide laser.
|
Academic Article
|
Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type.
|
Academic Article
|
Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates.
|
Academic Article
|
Effect of a T0 radical hysterectomy specimen on survival for early stage cervical cancer.
|
Academic Article
|
Epithelial ovarian tumors of low malignant potential: the role of microinvasion.
|
Academic Article
|
Phase I study and preliminary pharmacology of the novel innate immune modulator rBBX-01 in gynecologic cancers.
|
Academic Article
|
Differences in patterns of TP53 and KRAS2 mutations in a large series of endometrial carcinomas with or without microsatellite instability.
|
Academic Article
|
Cervical cancer suppressor gene is within 1 cM on 6p23.
|
Academic Article
|
Effects of cancer treatment on ovarian function.
|
Academic Article
|
Radical hysterectomy for cervical cancer in obese women.
|
Academic Article
|
Identification of chromosomal alterations important in the development of cervical intraepithelial neoplasia and invasive carcinoma using alignment of DNA microarray data.
|
Academic Article
|
Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer.
|
Academic Article
|
The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy.
|
Academic Article
|
A unified sample preparation protocol for proteomic and genomic profiling of cervical swabs to identify biomarkers for cervical cancer screening.
|
Academic Article
|
Ribosomal DNA methylation in patients with endometrial carcinoma: an independent prognostic marker.
|
Academic Article
|
Pathway index models for construction of patient-specific risk profiles.
|
Academic Article
|
Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction.
|
Academic Article
|
Clinical significance of microsatellite instability in endometrial carcinoma.
|
Academic Article
|
Factors predicting subcutaneous implanted central venous port function: the relationship between catheter tip location and port failure in patients with gynecologic malignancies.
|
Academic Article
|
MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
|
Academic Article
|
Cancer among first-degree relatives of probands with invasive and borderline ovarian cancer.
|
Academic Article
|
Cyclooxygenase-2 is overexpressed in human cervical cancer.
|
Academic Article
|
DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis.
|
Academic Article
|
Phase II evaluation of topotecan and navelbine in patients with recurrent ovarian, fallopian tube or primary peritoneal cancer.
|
Academic Article
|
Loss of heterozygosity in clinical stage IB cervical carcinoma: relationship with clinical and histopathologic features.
|
Academic Article
|
A microRNA expression signature for cervical cancer prognosis.
|
Academic Article
|
Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group.
|
Academic Article
|
Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes.
|
Academic Article
|
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.
|
Academic Article
|
Topotecan in platinum- and paclitaxel-resistant ovarian cancer.
|
Academic Article
|
Cervical intraepithelial neoplasia III shows frequent allelic loss in 3p and 6p.
|
Academic Article
|
Phase II trial of pyrazoloacridine in patients with persistent or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
|
Academic Article
|
Management of women at risk for malignancy.
|
Concept
|
Breast Neoplasms
|
Concept
|
Uterine Cervical Neoplasms
|
Concept
|
Abdominal Neoplasms
|
Concept
|
Genital Neoplasms, Female
|
Concept
|
Brain Neoplasms
|
Concept
|
Colorectal Neoplasms, Hereditary Nonpolyposis
|
Concept
|
Colonic Neoplasms
|
Concept
|
Uterine Neoplasms
|
Concept
|
Central Nervous System Neoplasms
|
Concept
|
Colorectal Neoplasms
|
Concept
|
Neoplasms, Glandular and Epithelial
|
Concept
|
Prostatic Neoplasms
|
Concept
|
Vulvar Neoplasms
|
Concept
|
Fallopian Tube Neoplasms
|
Concept
|
Gastrointestinal Neoplasms
|
Concept
|
Lung Neoplasms
|
Concept
|
Vaginal Neoplasms
|
Concept
|
Neoplasms, Second Primary
|
Concept
|
Endometrial Neoplasms
|
Concept
|
Head and Neck Neoplasms
|
Concept
|
Ovarian Neoplasms
|
Concept
|
Peritoneal Neoplasms
|
Concept
|
Neoplasms
|
Academic Article
|
AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake.
|
Academic Article
|
Hypermethylation of miR-203 in endometrial carcinomas.
|
Academic Article
|
3-T MRI-based adaptive brachytherapy for cervix cancer: treatment technique and initial clinical outcomes.
|
Academic Article
|
Polymorphisms in immune mediators associate with risk of cervical cancer.
|
Academic Article
|
Qualitative Evaluation of Medical Information Processing Needs of 60 Women Choosing Ovarian Cancer Surveillance or Prophylactic Oophorectomy.
|
Academic Article
|
Divergent viral presentation among human tumors and adjacent normal tissues.
|
Academic Article
|
Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain.
|
Academic Article
|
The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis.
|
Academic Article
|
Targeted, Deep Sequencing Reveals Full Methylation Profiles of Multiple HPV Types and Potential Biomarkers for Cervical Cancer Progression.
|
Academic Article
|
A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study.
|
Academic Article
|
Identification of a serum-induced transcriptional signature associated with metastatic cervical cancer.
|
Academic Article
|
Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.
|
Academic Article
|
Human papillomavirus oncogenes reprogram the cervical cancer microenvironment independently of and synergistically with estrogen.
|
Academic Article
|
Correction: Identification of a serum-induced transcriptional signature associated with metastatic cervical cancer.
|
Academic Article
|
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.
|
Academic Article
|
miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation.
|
Academic Article
|
HLA and KIR Associations of Cervical Neoplasia.
|
Academic Article
|
Genetic variations in human papillomavirus and cervical cancer outcomes.
|
Academic Article
|
The Immune Landscape of Cancer.
|
Academic Article
|
Adipose-only sentinel lymph nodes: a finding during the adaptation of a sentinel lymph node mapping algorithm with indocyanine green in women with endometrial cancer.
|
Academic Article
|
GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group study.
|
Academic Article
|
SOX11 hypermethylation as a tumor biomarker in endometrial cancer.
|
Academic Article
|
Preventive Effects by Black Raspberries of Endometrial Carcinoma Initiation and Promotion Induced by a High-Fat Diet.
|
Academic Article
|
Identification and validation of a prognostic proteomic signature for cervical cancer.
|
Academic Article
|
miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer.
|
Academic Article
|
ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R/STAT3 signaling axis.
|
Academic Article
|
Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199).
|
Academic Article
|
Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes.
|
Academic Article
|
Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth.
|
Academic Article
|
Multi-omics mapping of human papillomavirus integration sites illuminates novel cervical cancer target genes.
|
Academic Article
|
Student-centered Pipeline to Advance Research in Cancer Careers (SPARCC): Diversifying the Clinical Cancer Research Workforce.
|
Academic Article
|
RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site.
|
Academic Article
|
Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance.
|
Academic Article
|
Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. Cancers 2022, 14, 958.
|
Academic Article
|
An Exploratory Study of Neoadjuvant Cetuximab Followed by Cetuximab and Chemoradiotherapy in Women With Newly Diagnosed Locally Advanced Cervical Cancer.
|
Academic Article
|
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.
|
Grant
|
Enlisting HPV integration events to illuminate drivers and target treatment in invasive cervical cancer
|
Academic Article
|
Genomic structures and regulation patterns at HPV integration sites in cervical cancer.
|
Academic Article
|
Carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer.
|